BANK OF AMERICA CORP /DE/ - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$19,908,363
-4.0%
396,423
+20.8%
0.00%0.0%
Q2 2023$20,736,047
+11.6%
328,102
-20.6%
0.00%0.0%
Q1 2023$18,581,907
+26.2%
413,023
+22.9%
0.00%0.0%
Q4 2022$14,723,711
-19.6%
336,081
+21.0%
0.00%0.0%
Q3 2022$18,308,000
-9.6%
277,854
-30.7%
0.00%0.0%
Q2 2022$20,261,000
-13.6%
401,094
+9.3%
0.00%0.0%
Q1 2022$23,450,000
-23.3%
367,091
+28.5%
0.00%
-33.3%
Q4 2021$30,590,000
+13.9%
285,590
+9.4%
0.00%0.0%
Q3 2021$26,848,000
+18.0%
261,142
+1.0%
0.00%
+50.0%
Q2 2021$22,744,000
-3.1%
258,557
+7.2%
0.00%
-33.3%
Q1 2021$23,460,000
+6.3%
241,279
+22.6%
0.00%0.0%
Q4 2020$22,065,000
+1.3%
196,743
-16.2%
0.00%0.0%
Q3 2020$21,775,000
+85.1%
234,883
+55.7%
0.00%
+50.0%
Q2 2020$11,767,000
+128.1%
150,871
+71.1%
0.00%
+100.0%
Q1 2020$5,158,000
-16.3%
88,196
+14.6%
0.00%0.0%
Q4 2019$6,165,000
-74.5%
76,955
-76.6%
0.00%
-75.0%
Q3 2019$24,200,000
+127.0%
329,379
+191.5%
0.00%
+100.0%
Q2 2019$10,660,000
+3.4%
113,013
-12.2%
0.00%
+100.0%
Q1 2019$10,307,000
+107.4%
128,774
+39.7%
0.00%0.0%
Q4 2018$4,969,000
-53.4%
92,173
-32.5%
0.00%0.0%
Q3 2018$10,658,000
+20.1%
136,534
-2.3%
0.00%0.0%
Q2 2018$8,871,000
+61.3%
139,721
+133.0%
0.00%
Q1 2018$5,499,000
+71.3%
59,971
+40.8%
0.00%
Q4 2017$3,211,000
+256.8%
42,592
+229.6%
0.00%
Q3 2017$900,000
+209.3%
12,924
+125.2%
0.00%
Q2 2017$291,000
-10.2%
5,739
-29.1%
0.00%
Q1 2017$324,000
+194.5%
8,090
+105.0%
0.00%
Q4 2016$110,000
+205.6%
3,946
+222.1%
0.00%
Q3 2016$36,000
-23.4%
1,225
-47.4%
0.00%
Q2 2016$47,000
+193.8%
2,331
+165.5%
0.00%
Q1 2016$16,000
-95.2%
878
-93.1%
0.00%
Q4 2015$335,000
+116.1%
12,705
+74.4%
0.00%
Q3 2015$155,000
+2114.3%
7,284
+2712.4%
0.00%
Q2 2015$7,0002590.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders